ArticleJournal of managed care & specialty pharmacy2023

Comparison of a second TNFi vs other biologic or targeted synthetic DMARD following an initial TNFi.

Kori Asante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.